← Back to Search

Combination Therapy

Enstilar for Psoriasis

Phase 4
Recruiting
Research Sponsored by Psoriasis Treatment Center of Central New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial found that Enstilar, when used in combination with Taltz, was more effective in treating plaque psoriasis than when either drug was used alone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Surface Area 0 or 1

Side effects data

From 2018 Phase 4 trial • 28 Patients • NCT03441789
14%
rhinorrhea
7%
abdominal cramping
7%
thrombocytopenia
7%
chronic obstructive pulmonary disease exacerbation
7%
upper respiratory infection
7%
sinus tachycardia
7%
shortness of air
7%
diarrhea
7%
overactive bladder
7%
right flank pain
7%
nausea
7%
dyspnea at rest
7%
squamous cell carcinoma
7%
increased joint pain generalized
7%
chest congestion
7%
fall at home
100%
80%
60%
40%
20%
0%
Study treatment Arm
Otezla Plus Enstilar Foam
Otezla Plus Vehicle Foam

Trial Design

1Treatment groups
Experimental Treatment
Group I: EnstilarExperimental Treatment1 Intervention
Enstilar foam
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Calcipotriol
FDA approved

Find a Location

Who is running the clinical trial?

Eli Lilly and CompanyIndustry Sponsor
2,618 Previous Clinical Trials
3,206,523 Total Patients Enrolled
36 Trials studying Psoriasis
20,378 Patients Enrolled for Psoriasis
Psoriasis Treatment Center of Central New JerseyLead Sponsor
14 Previous Clinical Trials
417 Total Patients Enrolled
13 Trials studying Psoriasis
377 Patients Enrolled for Psoriasis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Taltz in Combination With Enstilar for Psoriasis
2020. "Taltz in Combination With Enstilar for Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04372277.
All > Psoriasis
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top